Form 4 for APRE Aprea Therapeutics, Inc.
Accepted 2024-10-16 00:00:00 ET · period of report 2024-10-11 · accession 0001104659-24-108962 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-16 | 2024-10-11 | APRE | Hamill John P. | CFO, SrVP, Prin Fin, Acct Ofcr | P - Purchase | $2.46 | +50 | 19.4K | +0.3% | +$123 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-11 | P | A | 50 | $2.46 | 19,368 | D | — | — |